Published in N Engl J Med on July 09, 1981
Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child (1983) 1.17
Early administration of indomethacin to preterm infants. Arch Dis Child (1986) 1.10
Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child (1991) 1.07
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol (2012) 1.07
Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates. Arch Dis Child (1989) 0.87
Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response. Br Heart J (1983) 0.81
Patent ductus arteriosus in premature babies. Br Med J (Clin Res Ed) (1981) 0.81
Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study. Br J Clin Pharmacol (2004) 0.81
Intravenous indomethacin for patent ductus arteriosus. Arch Dis Child (1984) 0.80
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit. Clin Perinatol (2012) 0.77
Prolonged low dose indomethacin for persistent ductus arteriosus. Arch Dis Child (1991) 0.76
Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. J Perinatol (2017) 0.75
Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. Pediatr Cardiol (2010) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics (1987) 4.10
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson (1999) 3.12
Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A (1995) 3.08
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem (1995) 2.43
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol (2001) 2.12
Purification of an allene oxide synthase and identification of the enzyme as a cytochrome P-450. Science (1991) 2.06
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00
Control of myocardial oxygen consumption: relative influence of contractile state and tension development. J Clin Invest (1968) 1.90
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem (2001) 1.87
Molecular cloning of an allene oxide synthase: a cytochrome P450 specialized for the metabolism of fatty acid hydroperoxides. Proc Natl Acad Sci U S A (1993) 1.87
Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res (1992) 1.86
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem (1998) 1.77
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med (1984) 1.73
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr (1987) 1.66
Increased survival rate in very low birth weight infants (1500 grams or less): no association with increased incidence of handicaps. J Pediatr (1990) 1.65
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem (1994) 1.58
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Straight phase separation of prostaglandin methyl esters on lipophilic gels. Prostaglandins (1974) 1.56
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Serum vitamin A levels in respiratory syncytial virus infection. J Pediatr (1994) 1.53
Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr (1978) 1.53
Right ventricular volume determinations in children. Normal values and observations with volume or pressure overload. Circulation (1973) 1.52
Identification of a naturally occurring peroxidase-lipoxygenase fusion protein. Science (1997) 1.52
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J Biol Chem (1990) 1.37
15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res (2001) 1.37
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
Purification and catalytic activities of the two domains of the allene oxide synthase-lipoxygenase fusion protein of the coral Plexaura homomalla. J Biol Chem (1999) 1.36
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem (1996) 1.32
Prognosis in hyaline-membrane disease. Use of a linear-discriminant. N Engl J Med (1967) 1.32
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med (1981) 1.32
Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr (1978) 1.31
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res (1985) 1.28
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol (1992) 1.28
Assessment of ventricular size and function in congenitally corrected transposition of the great arteries. Am J Cardiol (1983) 1.28
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation (1987) 1.27
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem (1982) 1.26
Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther (1977) 1.25
Investigation of the mechanism of biosynthesis of 8-hydroxyeicosatetraenoic acid in mouse skin. Biochim Biophys Acta (1991) 1.25
Cigarette smoking and hemostatic function. Am Heart J (1988) 1.23
Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem (1985) 1.22
Formation of a novel dihydroxy acid from arachidonic acid by lipoxygenase-catalyzed double oxygenation in rat mononuclear cells and human leukocytes. J Biol Chem (1982) 1.22
Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg (1981) 1.21
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest (1983) 1.21
Enantiomeric separation of hydroxy eicosanoids by chiral column chromatography: effect of the alcohol modifier. Anal Biochem (2000) 1.21
Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol (1982) 1.21
Left heart volume estimation in infancy and childhood. Reevaluation of methodology and normal values. Circulation (1971) 1.21
Absolute configuration of cis-12-oxophytodienoic acid of flaxseed: implications for the mechanism of biosynthesis from the 13(S)-hydroperoxide of linolenic acid. Biochemistry (1988) 1.20
Preparation and characterization of hydroperoxy-eicosatetraenoic acids (HPETEs). Prostaglandins (1980) 1.20
Operative management of renovascular hypertension. Results after a follow-up of fifteen to twenty-three years. J Vasc Surg (1984) 1.20
Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol (1979) 1.20
Membranous supravalvular mitral stenosis: a treatable form of congenital heart disease. J Am Coll Cardiol (1986) 1.18
Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr (1981) 1.18